tests

Alzheimer's disease (AD) is characterized by brain protein aggregates of amyloid-β (Aβ) and phosphorylated tau (pTau) that become plaques and tangles, and dystrophic neurites surrounding the plaques, which are accompanied by downstream…

SummaryIn the wake of the controversial U.S. regulatory approval of the Alzheimer's drug aducanumab, physicians expect many patients with memory problems will want to know whether they are eligible. But a definitive diagnosis is expensive…